PHARMACOLOGY UPDATE

Sofosbuvir and Velpatasvir Tablets (Epclusa)

September 1, 2016

The FDA has approved the first drug combination for the treatment of all six major genotypes of hepatitis C virus infections.

Issue Date: September 1, 2016

Table of Contents

Varicella Zoster Virus and Granulomatous Arteritis
Guideline Update: Adults with Hospital-acquired and Ventilator-associated Pneumonia
Antibiotics, Breastfeeding, and the Intestinal Microbiota
Steroids Increase the Risk for Community-acquired Staphylococcus aureus Bacteremia
Rotavirus Vaccination Prevents Febrile Seizures in Children
Sofosbuvir and Velpatasvir Tablets (Epclusa)
Infectious Disease Alert Updates

Infectious Disease Alert’s editor, Stan Deresinski, MD, FACP, FIDSA, reports no financial relationships relevant to this field of study; peer reviewer Patrick Joseph, MD, is laboratory director for Genomic Health, Siemens Corp., and CareDx; Updates author, Carol A. Kemper, MD, FACP, peer reviewer Kiran Gajurel, MD, continuing education and editorial director Lee Landenberger, executive editor Shelly Morrow Mark, and associate managing editor Jonathan Springston report no financial relationships to this field of study.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements